Kahira Pharmaceuticals & Chemical Industries Company (EGX:CPCI)
Egypt flag Egypt · Delayed Price · Currency is EGP
256.23
+2.94 (1.16%)
At close: Feb 2, 2026

EGX:CPCI Cash Flow Statement

Millions EGP. Fiscal year is Jul - Jun.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Net Income
513.05443.72246.1197.09165.74124.3
Depreciation & Amortization
42.3436.035.3215.94--
Other Amortization
0.010.010.010.01--
Other Operating Activities
-127.69-101.0411.45-24.52-113.9237.95
Operating Cash Flow
427.71378.72262.8988.5351.83162.25
Operating Cash Flow Growth
50.25%44.06%196.96%70.82%-68.06%-
Capital Expenditures
-134.05-139.47-216.24-79.07-17.31-23.68
Sale of Property, Plant & Equipment
---0.0800.04
Investment in Securities
---0.84-15.86-14.11
Other Investing Activities
22.7821.12-14.52.854.942.62
Investing Cash Flow
-111.27-118.35-231.58-76.143.49-35.13
Long-Term Debt Issued
--133.88144.31--
Long-Term Debt Repaid
--36.67-50.76-28.36--
Net Debt Issued (Repaid)
-40-36.6783.12115.95--
Common Dividends Paid
-220.8-220.78-85.53-100.82-75.2-77.73
Financing Cash Flow
-260.8-257.45-2.4115.13-75.2-77.73
Miscellaneous Cash Flow Adjustments
0-----
Net Cash Flow
55.642.9328.927.51-19.8949.39
Free Cash Flow
293.66239.2546.659.4534.52138.57
Free Cash Flow Growth
531.04%412.87%393.48%-72.61%-75.09%-
Free Cash Flow Margin
12.71%11.51%3.43%0.94%3.10%13.05%
Free Cash Flow Per Share
19.6616.023.120.632.319.28
Cash Interest Paid
---5.85--
Cash Income Tax Paid
84.469345.8973.1251.3336.22
Levered Free Cash Flow
227.46146.4-42.2657.94-20.1797.35
Unlevered Free Cash Flow
237.51154.86-30.4260.12-20.1797.35
Source: S&P Global Market Intelligence. Standard template. Financial Sources.